Academic journals are absolutely critical mate. Doctors only purchase products that have rigorous peer reviewed data and insurers wont cover them without that either. It's the main competitive advantage you can have. In this space, nothing is more important for ensuring long term success than peer reviewed data.
The Clinicians Speak, page-588
-
- There are more pages in this discussion • 446 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.36 |
Change
0.050(2.16%) |
Mkt cap ! $1.632B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.39 | $2.33 | $2.230M | 946.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3861 | $2.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 20817 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |